Alcon prices €500M senior notes due 2033
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alcon AG (ALCC)
The Alcon share price today is 58.46, view SIX ALCC stock exchange data. Track the latest Alcon share price with real-time updates on ALCC stock performance including market cap, day range, 52-week range and dividend yield. Access ALCC charts, earnings dates and analyst estimates to support your investment decisions.
58.46
-0.14(-0.24%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.80
58.54
52 wk Range
47.80
68.34
ALCC is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.8058.54
52 wk Range
47.8068.34
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ALCC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
73.66
Upside
+26.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
Alcon AG receives Investment Bank Analyst Rating Update- Investing.com
Pro
Alcon AG receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Alcon prices €500M senior notes due 2033
- Investing.com
- Alcon AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alcon AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Alcon AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
20 Buy
5 Hold
1 Sell
Ratings:
26 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 73.66
(+26.00% Upside)
Alcon AG Earnings Call Summary for Q2/2026
- Alcon Q2 2026 adj. EPS of $0.84 beat estimates by 10.86%; revenue of $2.78B topped forecasts; shares surged 6.31% to $62 after-hours.
- Core gross margin expanded 250 bps to 64.7% YoY; constant-currency sales rose 7% across surgical and vision care segments.
- Company raised FY 2026 guidance: 5-7% sales growth, 90-190 bps operating margin expansion, and 12-15% core EPS growth expected.
- Q3 to include ~$60M tariff refund with $40M reinvested in product launches including TRYPTYR, Valeda, UNITY CS, and PanOptix Pro.
- PowerVision IOL discontinued due to inconsistent clinical data; U.S. cataract market flat; reimbursement pressure persists in surgical glaucoma.
Last Updated: 11-08-2026, 06:48 pm
Read Full TranscriptEarnings
Latest Release
10-08-2026
EPS / Forecast
0.84 / 0.76
Revenue / Forecast
2.78B / 2.76B
Compare ALCC to Peers and Sector
Metrics to compare | ALCC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 54.7x | 23.8x | −0.4x | |
PEG Ratio | −1.39 | −0.07 | 0.00 | |
Price/Book | 1.6x | 2.3x | 2.6x | |
Price / LTM Sales | 3.2x | 3.2x | 3.1x | |
Upside (Analyst Target) | 28.9% | −1.8% | 46.0% | |
Fair Value Upside | Unlock | 11.9% | 5.3% | Unlock |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Alcon (ALCC) Share Price Today?
The Alcon share price today is 58.46.
What is the current Alcon (ALCC) share price and day range?
As of 27-08-2026, the Alcon share price is 58.46, with a previous close of 58.60. The share price has ranged from 57.80 to 58.54 today, while the 52-week range spans from 47.80 to 68.34.
What Is the Alcon Market Cap?
As of today, Alcon market cap is 28.11B.
Does Alcon Pay Dividends? What's The Current Dividend Yield?
The Alcon dividend yield is 0.48%.
What Is the Alcon (ALCC) Share Price Target?
The average 12-month share price target for Alcon is 73.66, with a high estimate of 84.66707594 and a low estimate of 47.75146996. 20 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +26.00% Upside potential.
What Is Alcon's Earnings Per Share (TTM)?
The Alcon EPS (TTM) is 1.31.
When Is the Next Alcon Earnings Date?
Alcon will release its next earnings report on 10-11-2026.
From a Technical Analysis Perspective, Is ALCC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Alcon Trade On?
Alcon is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Alcon?
The stock symbol for Alcon is "ALCC."
How Many Times Has Alcon Stock Split?
Alcon has split 0 times.
How Many Employees Does Alcon Have?
Alcon has 25000 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.